Literature DB >> 6310750

An opiate binding site in the rat brain is highly selective for 4,5-epoxymorphinans.

J Grevel, W Sadée.   

Abstract

In vitro binding studies have demonstrated the existence of multiple opiate receptor types. An additional site in the rat brain (termed the lambda site) is distinct from the established types by its selectivity for 4,5-epoxymorphinans (such as naloxone and morphine). While the lambda site displays a high affinity for naloxone in vivo and in vitro in fresh brain membrane homogenates, these sites rapidly convert in vitro to a state of low affinity. The regional distribution of the lambda site in the brain is strikingly different from that of the classic opiate receptor types.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310750     DOI: 10.1126/science.6310750

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Conformation and electrostatic potential surfaces of opiates: Relationship to µ- and λ-site binding.

Authors:  T P Lybrand; P A Kollman; V C Yu; W Sadée
Journal:  Pharm Res       Date:  1986-08       Impact factor: 4.200

Review 2.  Ethanol ingestive behavior as a function of central neurotransmission.

Authors:  K Blum; A H Briggs; M C Trachtenberg
Journal:  Experientia       Date:  1989-05-15

3.  Beta-funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons.

Authors:  C P France; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes.

Authors:  R L Gannon; D M Terrian
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

5.  Radioreceptor assay of narcotic analgesics in serum.

Authors:  J Grevel; J Thomas; M L Richards; W Sadée
Journal:  Pharm Res       Date:  1984-09       Impact factor: 4.200

6.  The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides.

Authors:  Max Meyrath; Martyna Szpakowska; Julian Zeiner; Laurent Massotte; Myriam P Merz; Tobias Benkel; Katharina Simon; Jochen Ohnmacht; Jonathan D Turner; Rejko Krüger; Vincent Seutin; Markus Ollert; Evi Kostenis; Andy Chevigné
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

Review 7.  Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.

Authors:  Wolfgang Sadee; John Oberdick; Zaijie Wang
Journal:  Molecules       Date:  2020-09-11       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.